We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VACN:SIXVAT Group AG Analysis

Data as of 2026-05-17 - not real-time

CHF 598.60

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading near its annual high, comfortably above short‑ and medium‑term moving averages, which signals a bullish price backdrop. Momentum indicators such as the RSI sit in the upper‑mid range, suggesting continued buying pressure without being overbought. However, the MACD histogram has turned negative, hinting at a possible short‑term pullback. The market’s sentiment index reads in the “Extreme Greed” zone, reflecting strong investor optimism. Valuation metrics show the price is far above both comparable peers and the discounted cash‑flow estimate, indicating a significant premium. Despite this, the company’s earnings growth and robust margins provide a cushion against the lofty multiple.
Fundamentals reveal a healthy profit margin profile and a solid return on equity, underscoring strong operational efficiency. Cash generation is ample, with free cash flow comfortably covering the dividend, yet the payout ratio approaches the upper limit of sustainability. The balance sheet is modestly leveraged, and the low beta suggests limited systematic risk. Geographic diversification across Europe, North America and Asia spreads exposure, while the industrial machinery sector carries moderate cyclical risk. Overall, the stock presents a mixed picture: attractive earnings quality but an overvalued price tag. Consequently, a cautious stance is advised—maintain exposure in the near term while positioning for potential upside as the market re‑prices the fundamentals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near annual high
  • MACD bearish divergence
  • high valuation premium

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • strong operating margins
  • robust cash flow
  • analyst consensus buy

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • defensible niche in vacuum valve market
  • recurring service revenue
  • solid return on equity

Key Metrics & Analysis

Financial Health

Revenue Growth4.70%
Profit Margin19.96%
P/E Ratio84.1
ROE27.70%
ROA12.34%
Debt/Equity31.30
P/B Ratio22.6
Op. Cash FlowCHF299.2M
Free Cash FlowCHF137.6M
Industry P/E29.6

Technical Analysis

TrendBullish
RSI57.9
SupportCHF 545.00
ResistanceCHF 629.60
MA 20CHF 587.37
MA 50CHF 544.21
MA 200CHF 416.73
MACDBearish
VolumeStable
Fear & Greed Index88.52

Valuation

Fair ValueCHF 70.61
Target PriceCHF 597.24
Upside/Downside-0.23%
GradeOvervalued
TypeGrowth
Dividend Yield1.17%

Risk Assessment

Beta0.35
Volatility42.04%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.